Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code

Current Articles

2025, Volume 45,  Issue 12

Cover Catalogue
Reviews
Research progress on immunomodulatory effects and role of bile acids and bile acid receptors in the occurrence and development of colorectal cancer
LIU Zhijun, CUI Lili, XU Fengjing, SONG Xinhua, WANG Zhipeng, GAO Shouhong
2025, 43(12): 583-590. doi: 10.12206/j.issn.2097-2024.202312024
Abstract(4766) HTML (3912) PDF (1357KB)(17)
Abstract:
Colorectal cancer is one of the most common malignant tumors, which is a great threat to human life and health. The change of bile acid homeostasis can activate their corresponding receptors to regulate the immune functions, which is closely related to the occurrence of colorectal cancer. In addition, some bile acids can directly induce colorectal cancer and play an important role in the development of colorectal cancer. In this paper, the metabolic process of bile acids in vivo and the immunomodulatory role of bile acid receptors were reviewed, and the evidence of associations between bile acids and colorectal cancer were summarized, which showed the rebalancing the bile acid levels might play a role in the prevention or treatment of colorectal cancer.
Original articles
Mechanism of Xiakucao Xiaoliu Mixture against non-small cell lung cancer by network pharmacology
HU Yue, YIN Yong, SHI Liuhui, XU Xiaohong, ZHU Jianyong, NIAN Hua
2025, 43(12): 591-598. doi: 10.12206/j.issn.2097-2024.202302020
Abstract(1223) HTML (239) PDF (2366KB)(11)
Abstract:
  Objective   To explore the mechanism of Xiakucao Xiaoliu Mixture against non-small cell lung cancer (NSCLC).   Methods  The effective components of Xiakucao Xiaoliu Mixture were screened by TCMSP, BATMAN-TCM database and literature reviews. The targets of effective components were predicted. NSCLC related targets were collected by GeneCards, OMIM, PharmGKB, TTD and Drugbank, combined with the differential genes of Xiakucao Xiaoliu Mixture against Lewis lung cancer mice. The intersection targets of Xiakucao Xiaoliu Mixture against NSCLC were obtained. Cytoscape software was used to construct the network diagram of traditional Chinese medicine-active ingredients-core targets. STRING database was used to construct PPI network diagram. GO function enrichment analysis and KEGG pathway enrichment analysis of the intersection targets were performed by Metascape database to predict the key targets and active components of Xiakucao Xiaoliu Mixture against NSCLC, and Schrodinger software was used to perform molecular docking verification.   Results  The 32 active components and 24 intersection targets of Xiakucao Xiaoliu Mixture against NSCLC were obtained. 11 core targets such as ESR1, MAPK1 were found. The mechanism of action may be related to 30 signaling pathways such as cellular senescence, receptor activation, prolactin signaling pathway.   Conclusion  The active components of Xiakucao Xiaoliu Mixture act on multiple targets and signaling pathways to regulate complex biological processes. By regulating ESR1 agsinst NSCLC, it may play an important role in improving the survival rate and prognosis of female patients.
Effect of different conditions of solid phase extraction column on determination of morphine in compound liquorice oral solution
LIU Linlin, ZHONG Guixiang, YAN Jia, ZHOU Xin
2025, 43(12): 599-602. doi: 10.12206/j.issn.2097-2024.202311012
Abstract(926) HTML (190) PDF (860KB)(9)
Abstract:
  Objective  To explore the effect of different packing contents of solid phase extraction column, repeated use times and solid phase extraction column under pressure on the determination of morphine content in compound liquorice oral solution.   Methods  The component was performed by high performance liquid chromatography (HPLC) equipped with the C8 (4.6 mm × 150 mm, 5 μm) chromatographic column. The mobile phase consisted of acetonitrile-2.5 mmol/L sodium heptanesulfonate solution-50 mmol/L potassium dihydrogen phosphate solution (5∶18∶18). The flow rate was 1.0 ml/min with the 220 nm detection wavelength, 20 μl injection volume and 30℃ column temperature.   Results  It was found that the SPE column produced of 500 mg had a higher recovery rate of morphine, and the RSD value was small. It was found that SPE column could be reused for up to 3 times under the condition of guaranteeing recovery rate.In the pressurized experiment,at the flow rate of 0.5 ml/min, the measured morphine content was basically consistent with that measured at atmospheric pressure.   Conclusion  The determination of morphine in compound liquorice oral solution could be carried out by C18 solid phase extraction column of 500 mg. Under pressure, the flow rate was about 0.5 ml/min for morphine recovery, which could achieve high recovery of morphine in compound liquorice oral solution and improve the detection efficiency of morphine.
Research reports
Research and establishment of standards for traditional Chinese medicine sachet
XIN Hailiang, JIANG Yiping, HAN Ting, GUO Tao, NIAN Hua, YUE Xiaoqiang
2025, 43(12): 603-606, 613. doi: 10.12206/j.issn.2097-2024.202402004
Abstract(2867) HTML (869) PDF (1342KB)(31)
Abstract:
  Objective   Fragrant sachets are items with significant Chinese cultural characteristics and have multiple application values, with their medicinal value being an important aspect. Especially in recent years, with the successive outbreaks of SARS, MERS, COVID-19, the medicinal effect of traditional Chinese medicine sachets has been increasingly valued and widely used.However, there are no relevant standards for traditional Chinese medicine sachets at the national, industry, local, or organizational levels, which is not conducive to the healthy development of the industry. To establish standards for traditional Chinese medicine sachets to lead the development of the industry.   Methods  Based on the review of the current application status of traditional Chinese medicine sachets, a study on the quality standards of traditional Chinese medicine sachets was conducted through investigation and research, data collection, drafting of standard drafts, soliciting opinions, review and approval, and standard verification.   Results   The first group standard of traditional Chinese medicine sachet in China: Technological specification of traditional Chinese medicine sachet (powder core), which ensures the scientificity, progressiveness, rationality and practicability of the production of the standard of traditional Chinese medicine sachet.   Conclusion   The established group standard for traditional Chinese medicine sachets are practical, safe, reliable, and easy to implement, providing technical references for the inheritance and promotion of traditional Chinese medicine sachets.
Study on bacterial endotoxin limit value and the detection methodological investigation for the active pharmaceutical ingredient of pentetic acid
SHEN Juan, TIAN Ying, NI Ming, LIU Ju, YU Mengmeng
2025, 43(12): 607-609, 624. doi: 10.12206/j.issn.2097-2024.202508061
Abstract(1179) HTML (507) PDF (1180KB)(9)
Abstract:
  Objective  To explore and establish the bacterial endotoxin limit value and testing method of the active pharmaceutical ingredient (API) of pentetic acid, and conduct methodological investigation.   Methods  Three batches of pentetic acid were used to establish the method for the determination of bacterial endotoxin, and interference test was conducted simultaneously. The sample was dissolved with commercially available alkaline regulator to a concentration of 4 mg/ml or lower, and then diluted with water for bacterial endotoxin test. Limulus reagent with sensitivity of 0.125 EU/ml or higher was selected and redissolved with commercially available magnesium ion buffer solution. And the endotoxin test was performed by gel method.   Results  The endotoxin limit of API of pentetic acid was determined as: less than 0.125 EU/mg.   Conclusion  The method established could be used for the control of bacterial endotoxin in API of pentetic acid.
Medicine & Clinical
Therapeutic drug monitoring and clinical application of fruquintinib
CHEN Ming, WANG Chenjia, TANG Yuanjun, WANG Shuowen, FAN Guorong
2025, 43(12): 610-613. doi: 10.12206/j.issn.2097-2024.202412043
Abstract(1141) HTML (320) PDF (1018KB)(14)
Abstract:
  Objective  To establishing a chromatographic analysis method for therapeutic drug monitoring of fruquintinib by high-performance liquid chromatography (HPLC).   Methods  The analysis was conducted using a Welch Ultimate XB-C18 (4.6 mm×150 mm, 5 μm) column with the column temperature at 35℃. The flow rate was 1.0 ml/min and the detection wavelength was at 240 nm. The mobile phase consisted of acetonitrile and 10 mmol/L potassium dihydrogen phosphate (pH 3.15)= 40∶60(VV). The internal standard substance was Apatinib.All plasma samples were extracted with ethyl acetate solution.  Results  The linearity of Fruquintinib in plasma was good within the range of 15.63-500.00 ng/ml (r=0.999 9). The recoveries of the method were between 95%-110% with the RSD less than 10%. The extraction rates of the method were all higher than 97%. The stability tests met the relative requirements.   Conclusion  A HPLC method for the determination of Fruquintinib in human plasma was established. The method had good specialty, and could be used to detect the blood concentrations of Fruquintinib in clinical practice to improve the individualized medication.
Reasonable management and control practice of prophylactic use of antibiotics in urinary system lithotripsy
CHEN Yijun, WANG Zhuo, HE Miao, ZHANG Yu, TIAN Jing
2025, 43(12): 614-618. doi: 10.12206/j.issn.2097-2024.202402034
Abstract(7383) HTML (2559) PDF (1000KB)(26)
Abstract:
  Objective   To analyze the effectiveness of reasonable control measures for prophylactic use of antibiotics in urinary system lithotripsy.   Methods   By antimicrobial stewardship, strengthening special comments on antibiotics and information notification on rational use of antibiotics, adding and improving the pre-review rules for antibiotics prescriptions, conducting in-depth clinical training and consultation by clinical pharmacists, strengthening innovation in rational use of drugs, and taking various measures to actively improve rational use of prophylactic antibiotics of lithotripsy in urology department, the changes of indexes related to antibiotics in urology department from 2019 to 2022 were analyzed.   Results   After active and reasonable control, Antibiotics Use Density in urology department decreased year by year. The utilization rate of antibiotics in inpatients decreased from 94.27% in 2019 to 77.47% in 2022. Various rate of microbial inspection reached the standard in 2022. The imipenem and cilastatin sodium for injection ranking of prophylactic use of antibiotics consumption DDDs for urinary system lithotripsy decreased from the 4th place in 2019 to the 8th place in 2022. The ranking of the urology department on carbapenem consumption DDDs in the whole hospital decreased from the 8th place in 2019 to the 12th place in 2022. At the same time, the incidence of urinary tract lithotripsy postoperative infection showed a decreasing trend year by year, from 0.84% in 2019 to 0.49% in 2022.   Conclusion  Positive control measures can promote the rational use of prophylactic antibiotics for urinary system lithotripsy.
Pharmacy administration
Cost effectiveness analysis between osimertinib and gefitinib in the treatment of advanced non-small cell lung cancer with epidermal growth factor receptor mutation
LI Na, HUANG Chengwen, SUN Xiujuan, WANG Xiaohong, ZHANG Li, WANG Xingpo
2025, 43(12): 619-624. doi: 10.12206/j.issn.2097-2024.202411032
Abstract(3318) HTML (615) PDF (970KB)(12)
Abstract:
  Objective  To explore the cost effectiveness of osimertinib and gefitinib in the treatment of advanced non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutation.   Methods  A total of 52 advanced NSCLC patients with EGFR mutation treated by osimertinib were selected as group A from June 2021 to August 2022 at the Chengde Central Hospital, and 52 patients treated by gefitinib were selected as group B according to the propensity score matching method in 1∶1 ratio. The treatment cost and effect of the two groups of patients were compared, and the cost-effectiveness ratio was calculated, and sensitivity analysis was conducted.   Results  The total effective rate of group A was higher than that of group B (90.38% vs 71.15%, χ2=6.190, P=0.013). The drug cost and total treatment cost of group A were higher than those of group B(P<0.05), and other direct costs were lower than those of group B (P<0.05). The incremental cost effectiveness ratio of group A was 374.71. After the cost-effectiveness sensitivity analysis on adjusting drug costs to decrease by 10% and the total effective rate to decrease by 10% of the two groups, the sensitivity analysis results were basically consistent with the original results.   Conclusion  Based on the latest prices and actual case data of osimertinib and gefitinib, osimertinib was better than gefitinib in the treatment of advanced NSCLC patients with EGFR mutation. Although gefitinib had lower treatment costs, osimertinib had more cost effectiveness advantages. These findings could provide important reference for the clinical development of treatment plans for advanced NSCLC patients with EGFR mutations.
Application of information technology in drug safety in China by bibliometric analysis
LIU Guizhu, LI Hang, WANG Nan, WANG Fang, HU Xu, TANG Jiajie
2025, 43(12): 625-630, 636. doi: 10.12206/j.issn.2097-2024.202303027
Abstract(3826) HTML (823) PDF (2640KB)(12)
Abstract:
  Objective  To sort out the current situation and research hotspots of the application of information technology in drug safety in China, reveal the latest research frontier, and provide a basis for the follow-up research.   Methods  The literature about the application of information technology in the field of drug safety were searched from 2012 to 2022 in three major databases of CNKI, WanFang and VIP databases, and visual analysis was conducted with the help of Citespace software.   Results  A total of 848 valid papers were included, and the number of annual publications showed a phased growth trend, and the cooperation between authors and publishers was not close enough. The application of information technology in drug safety was mainly reflected in pharmaceutical service, intravenous drug dispensing center and antibacterial drugs. The main technical means of information construction in the field of drug safety were prescription pre-audit system, knowledge base and automation. The research frontiers were mainly intelligence, knowledge base, prescription audit, and proprietary Chinese medicines.   Conclusion  The application of information technology in drug safety in China is in a period of vigorous development, and cooperation among different regions, institutions, and authors should be strengthened to promote information sharing. In the future, the related research of information technology in the field of Chinese patent medicine should be focused, and the research content of information technology application in drug safety could be further improved.
Analysis of medication use in sample pediatric hospitals
DU Yue, LI Jiali, CHAI Yu, CHEN Shaoqing, ZHAN Qi
2025, 43(12): 631-636. doi: 10.12206/j.issn.2097-2024.202404071
Abstract(3339) HTML (503) PDF (966KB)(23)
Abstract:
  Objective  To analyze the usage of pediatric drugs in 17 pediatric specialty hospitals from 2016 to 2020, and provide reference and guidance for the development of the essential medicine list (EML) for children and the improvement of the National Reimbursement Drug List (NRDL) in China.   Methods   Based on the pediatric medication monitoring data from 17 children's specialized hospitals reported to the Chinese Medical Economic Information Network (CMEI) of the Chinese Pharmaceutical Association between 2016 and 2020, this study analyzes the overall situation of the sample hospitals and the clinical use of pediatric drugs according to the major categories of the Anatomical Therapeutic Chemical Classification System (ATC).   Results   In the various ATC categories, the trend of systemic use of anti-infective drugs decreasing was significant in the average hospital expenditure, while the trend of respiratory and digestive system and metabolic drugs decreasing was significant in the average hospital DDDS. In 2020, the average number of hospital grade standards for essential drugs (2018 version) accounted for 15.82% of the total number of drug use standards, while the average number of hospital grade standards for medical insurance (2019 version) accounted for 8.23% of the total number of drug use standards.   Conclusion   The use of pediatric medication in sample hospitals from 2016 to 2020 was generally reasonable, and there would still a certain gap between the actual clinical usage habits with the existing EML and NRDL, which still need to be adjusted.